Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Evžen Gregora"'
Autor:
Alexandra Jungova, Luděk Pour, Tomas Jelinek, Jakub Radocha, M Sýkora, Evžen Gregora, A. Heindorfer, Lucie Brožová, Roman Hájek, Vladimir Maisnar, Ivan Spicka, Jiří Minařík
Publikováno v:
Annals of Hematology. 98:951-962
The main goal was to find a simple prognostic to evaluate overall survival of patients older than 65 years of age with myeloma. Retrospective registry-based analysis from the Registry of Monoclonal Gammopathies was conducted. Patients over 65 years w
Autor:
Walter Bouwmeester, Evžen Gregora, Michal Sýkora, Roman Hájek, Marco Campioni, MJ Treur, Ludek Pour, Petr Kessler, Sebastian Gonzalez-McQuire, Jiri Minařík, Ivan Spicka, Lucy DeCosta, Hana Fraňková, Vladimir Maisnar, Jiri Jarkovsky
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e219-e240
Introduction Real-world data on patient outcomes and treatment patterns in multiple myeloma (MM) are limited. Materials and Methods The present noninterventional, observational, retrospective analysis of prospectively collected Czech patient medical
Autor:
Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Smoldering multiple myeloma (SMM) is an asymptomatic precursor to active multiple myeloma (MM). The aim of this study was to report clinical characteristics and outcomes of patients with SMM stratified based on their risk of progression to M
Externí odkaz:
https://doaj.org/article/ac4fa0e66df54bf9a47e4350692f9954
Autor:
Jiri Minarik, R Velichova, Alexandra Jungova, Ivan Spicka, Vladimir Maisnar, Evžen Gregora, Roman Hájek, Martin Stork, Sabina Ševčíková, Lucie Brozova, Tomas Jelinek, Luděk Pour
Publikováno v:
Neoplasma. 67(1)
Nowadays, bortezomib, a proteasome inhibitor, is widely used in treatment of newly diagnosed or relapsed multiple myeloma. The aim of this study was to analyze efficiency of bortezomib retreatment in patients with relapsed or refractory multiple myel
Autor:
Ivan Spicka, Alexandra Jungova, Jiří Jarkovský, Roman Hájek, Lucie Brozova, Evžen Gregora, Luděk Pour, Vladimir Maisnar, Jiri Minarik
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 30(Supplementum2)
Monoclonal gammopathy of undetermined significance (MGUS) and smouldering multiple myeloma (SMM) are premalignant stages of multiple myeloma (MM). MM is a malignancy of plasma cells, which is associated with a median overall survival of 5 to 7 years.
Autor:
Sabina Ševčíková, Zdeněk Adam, I. Vonke, Aneta Mikulasova, Jiří Jarkovský, Marta Krejčí, Vladimir Maisnar, Jarmila Obernauerova, Ivan Spicka, Lenka Zahradová, Petr Kessler, Luděk Pour, Viera Sandecká, Lucie Říhová, Vlastimil Scudla, Zdeněk Král, Dagmar Adamova, L. Walterová, Lucie Brožová, Jiří Minařík, Roman Hájek, Kamila Valentova, Jan Straub, Evžen Gregora, David Starostka, Jakub Radocha, Marek Wrobel
Publikováno v:
European journal of haematology. 99(1)
IntroductionMonoclonal gammopathy of undetermined significance (MGUS) is a premalignant condition with a risk of malignant conversion. Patients and methodsWith the aim to estimate the cumulative risk MGUS progression to hematologic malignancies, we a
Autor:
Ludmila Vodickova, Miguel Inacio da Silva Filho, Christian Langer, Luděk Pour, Markus M. Nöthen, Niels Weinhold, Hartmut Goldschmidt, Per Hoffmann, Pavel Vodicka, Karl-Heinz Jöckel, Hauke Thomsen, Asta Försti, Evžen Gregora, Roman Hájek, Kari Hemminki, Chiara Campo
Objectives To identify germ line variants contributing to the development of monoclonal gammopathy of undetermined significance (MGUS), an asymptomatic premalignant precursor for multiple myeloma (MM). Methods We conducted the first genomewide associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e4af311023c23ced922b22c1e9d82c
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85019753807
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85019753807
Autor:
Lubica Forraiová, Jiří Minařík, Vlastimil Scudla, Roman Hájek, Vladimir Maisnar, Evžen Gregora, Tomáš Büchler, Pavol Kotouček, Jaroslav Malý, Vladimír Bláha, Miloš Tichý, Adriana Kafková, Jakub Radocha
Publikováno v:
Bone Marrow Transplantation. 41:51-54
Immunoglobulin D (IgD) multiple myeloma (MM) is a rare plasma cell disorder constituting less than 2% of all MM cases. Survival of patients with IgD MM is generally shorter than that of patients with other types of monoclonal (M-) protein. We have re
Publikováno v:
Bone Marrow Transplantation. 30:953-961
We conducted a controlled, double-blind study of parenteral glutamine supplementation in an unselected group of consecutive autologous transplant patients. Patients received 30 g of alanyl-glutamine dipeptide (Dipeptiven; Fresenius-Kabi, Bad Homburg,
Autor:
Zdenek Adam, Dana Králová, Evžen Gregora, Luděk Pour, Roman Hájek, Krivanová A, M al Sahmani, Lenka Zahradová, Viera Sandecká, Petr Pavlicek, Marta Krejčí, Vladimir Koza, Miroslava Schützová
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S44-S45